www.fiercehealthcare.com
Open in
urlscan Pro
104.17.131.109
Public Scan
Submitted URL: https://qtx.omeclk.com/portal/wts/ue%5EcmQ6gE%7C6bbMnSaDr0vqnz0z7kqb8dPjggjfPyOc
Effective URL: https://www.fiercehealthcare.com/providers/accelerating-solutions-cancer-through-impact-investing?utm_medium=email&utm_source=nl&...
Submission: On October 14 via manual from US — Scanned from CA
Effective URL: https://www.fiercehealthcare.com/providers/accelerating-solutions-cancer-through-impact-investing?utm_medium=email&utm_source=nl&...
Submission: On October 14 via manual from US — Scanned from CA
Form analysis
2 forms found in the DOMGET /search-results
<form action="/search-results" method="get">
<fieldset class="d-flex align-items-center position-relative input-search">
<input type="text" placeholder="Search" name="fulltext_search" class="search-text w-100">
<button class="search-submit d-flex align-items-center" id="header-search-submit" type="submit" aria-label="search">
<svg aria-hidden="true" focusable="false" data-prefix="far" data-icon="search" class="svg-inline--fa fa-search fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512">
<path fill="currentColor"
d="M508.5 468.9L387.1 347.5c-2.3-2.3-5.3-3.5-8.5-3.5h-13.2c31.5-36.5 50.6-84 50.6-136C416 93.1 322.9 0 208 0S0 93.1 0 208s93.1 208 208 208c52 0 99.5-19.1 136-50.6v13.2c0 3.2 1.3 6.2 3.5 8.5l121.4 121.4c4.7 4.7 12.3 4.7 17 0l22.6-22.6c4.7-4.7 4.7-12.3 0-17zM208 368c-88.4 0-160-71.6-160-160S119.6 48 208 48s160 71.6 160 160-71.6 160-160 160z">
</path>
</svg>
</button>
<input type="hidden" placeholder="Search" name="dns" value="fiercehealthcare_com,fiercebiotech_com,fiercepharma_com">
</fieldset>
</form>
GET /search-results
<form class="w-100" action="/search-results" method="get">
<fieldset class="d-flex justify-content-between position-relative input-search">
<input type="text" placeholder="Search" name="fulltext_search" class="search-text w-100">
<button class="search-submit d-flex align-items-center" id="search-submit" type="submit" aria-label="search">
<svg aria-hidden="true" focusable="false" data-prefix="far" data-icon="search" class="svg-inline--fa fa-search fa-w-16" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512">
<path fill="currentColor"
d="M508.5 468.9L387.1 347.5c-2.3-2.3-5.3-3.5-8.5-3.5h-13.2c31.5-36.5 50.6-84 50.6-136C416 93.1 322.9 0 208 0S0 93.1 0 208s93.1 208 208 208c52 0 99.5-19.1 136-50.6v13.2c0 3.2 1.3 6.2 3.5 8.5l121.4 121.4c4.7 4.7 12.3 4.7 17 0l22.6-22.6c4.7-4.7 4.7-12.3 0-17zM208 368c-88.4 0-160-71.6-160-160S119.6 48 208 48s160 71.6 160 160-71.6 160-160 160z">
</path>
</svg>
</button>
</fieldset>
</form>
Text Content
Fierce Healthcare Continues Here ▼ Advertisement * Fierce Pharma * Fierce Biotech * Fierce Healthcare * Fierce Life Sciences Events * Advertise * About Us * Providers * Hospitals * Practices * Retail * Health Tech * AI and Machine Learning * Digital Health * Telehealth * Payers * Regulatory * Finance * Special Reports * Fierce 50 * Special Report * Awards Gala * Resources * Webinars * Fierce Events * Industry Events * Podcasts * Survey * Whitepapers * Events * Subscribe Subscribe * Providers * Hospitals * Practices * Retail * Health Tech * AI and Machine Learning * Digital Health * Telehealth * Payers * Regulatory * Finance * Special Reports * Fierce 50 * Special Report * Awards Gala * Resources * Webinars * Fierce Events * Industry Events * Podcasts * Survey * Whitepapers * Events * Subscribe * Fierce Pharma * Fierce Biotech * Fierce Healthcare * Fierce Life Sciences Events * Advertise * About Us Some doctors are using public genAI chatbots in clinical decisions. Is it safe? Providers ACCELERATING SOLUTIONS TO CANCER THROUGH IMPACT INVESTING By Ayla Ellison, Anastassia Gliadkovskaya Sep 25, 2024 9:15am Podnosis American Cancer Society cancer research Venture Capital (Questex) Certain cancer rates are on the rise, and outcome inequities remain a major public health concern. Getting into clinical trials is difficult, care is fragmented and treatments can be prohibitively expensive. Meanwhile, research for many cancers is underfunded. The American Cancer Society is on a mission to end cancer as we know it. Its venture capital and impact investment arm, BrightEdge, invests in early-stage companies developing therapeutics, diagnostics, devices and technologies that share in this goal. In this week’s episode of “Podnosis,” Fierce Healthcare’s Anastassia Gliadkovskaya chats with BrightEdge’s managing director Alice Pomponio about how the organization leans into its expertise in research, patient support and advocacy when working with entrepreneurs, what it looks for in emerging companies and how it measures their impact. TO LEARN MORE ABOUT THE TOPICS IN THIS EPISODE: * What will it take to improve the future of cancer care? Clinicians, patients stress better collaboration and reimbursement * American Cancer Society, Color Health team up to boost cancer screenings for employees * American Cancer Society, ASCO join forces to create 'credible' online cancer information under one roof TO LISTEN TO MORE EPISODES FROM PODNOSIS Check Out the Full List Podnosis American Cancer Society cancer research Venture Capital Oncology Providers Resource Center Sponsored HOW VIRTUAL SECOND OPINIONS HELP IMPROVE CARE FOR CANCER - AND REDUCE COSTS The rising cost of cancer care in the U.S. highlights the critical role virtual second opinions play in improving outcomes. Sponsored HOW VIRTUAL SECOND OPINIONS HELP IMPROVE CARE FOR CARDIOVASCULAR DISEASE – AND REDUCE COSTS Nearly half of all adults in the U.S. have at least one form of cardiovascular diseases, which cost $363 billion annually. LOOKING FOR MORE? Visit The Clinic by Cleveland Clinic's Resource Center for this content and others! RELATED CONTENT UPMC Health Plan taps veteran leader as new CEO Oct 14, 2024 01:00pm Chutes & Ladders — OMNY, Counterpart Health make C-suite hires; Cityblock taps new president Oct 14, 2024 11:00am AI-Driven Collaboration Takes Center Stage at Health Industry Conference Oct 14, 2024 08:00am Alex Azar Champions Value-Based Care at Fierce Health Payer Summit Oct 14, 2024 08:00am See more articles * Connect * The Team * Advertise * Join Us * Newsletters * Resources * RSS Feeds * Editorial Advisory Council * Our Brands * Fierce Pharma * Fierce Biotech * Fierce Healthcare * Our Events * Life Sciences Events ©2024 Questex LLC All rights reserved. Terms of use Privacy Policy Privacy Settings